A recent study published in Current Alzheimer Research with the National Library of Medicine suggests that individuals who use cannabis for non-medical purposes may have a reduced risk of cognitive decline. The study analyzed data from 4,744 adults aged 45 and older to determine the impact of cannabis consumption on subjective cognitive decline (SCD). SCD was defined as self-reported confusion or memory loss in the past year.
The study found that non-medical cannabis use was significantly associated with a 96% decreased odds of subjective cognitive decline. While the use of medical cannabis or a combination of recreational and medical cannabis also showed decreased odds, the results were not statistically significant.
Lead author Zhi Chen noted that the different compounds in cannabis, such as CBD and THC, may contribute to these outcomes. Medical cannabis, which typically contains higher levels of CBD, did not show the same cognitive health benefits as recreational cannabis, which is usually higher in THC.
Some memory care providers have already incorporated cannabis use as a treatment for residents experiencing agitation or anxiety. Silverado, a California-based memory care operator, uses cannabis products with families’ permission as an alternative to stronger medications for certain residents.
Kim Butrum, senior vice president of clinical services at Silverado, stated that there has been a noticeable increase in the use of cannabis for dementia treatment, with ongoing research exploring its anti-inflammatory and analgesic effects. Physicians at Silverado are hopeful that further research will support the expanded use of cannabis in memory care in the future.
